You are here: Industry Insights > Novavax

News List

Novavax partners with Takeda to develop Covid-19 vaccine in Japan pharmaceutical-technology
August 11, 2020
US-based biotechnology firm Novavax has partnered with Takeda Pharmaceutical to develop, manufacture and commercialise its Covid-19 vaccine candidate, NVX‑CoV2373, in Japan.
Novavax and Serum Institute of India Announce Collaboration contractpharma
August 11, 2020
Serum Institute gains exclusive rights to commercialize in India and non-exclusive rights to commercialize in other LMIC countries.
Novavax’s COVID-19 vaccine produces immune response in early study pharmatimes
August 07, 2020
Novavax has reported positive results from the Phase I portion of its Phase I/II study of its COVID-19 vaccine candidate NVX-CoV2373.
Novavax presents positive data from Phase I COVID-19 vaccine trial europeanpharmaceuticalreview
August 07, 2020
A Phase I trial conducted by Novavax to test NVX‑CoV2373, the company’s recombinant COVID-19 vaccine candidate, showed it elicited robust antibody responses.
Novavax signs deal with Serum Institute of India for COVID-19 vaccine supply expresspharma
August 07, 2020
Serum Institute of India will have exclusive rights for the vaccine in India during the term of the deal.
Novavax, FUJIFILM Initiate Large Scale Mfg. of COVID-19 Vax Candidate contractpharma
July 27, 2020
FUJIFILM to manufacture bulk drug substance for NVX-CoV2373 from its site in Morrisville, NC for Phase III trial.
Novavax receives $1.6bn from US Government for Covid-19 vaccine pharmaceutical-technology
July 08, 2020
Novavax has received $1.6bn under the US Government’s Operation Warp Speed (OWS) programme to support the development and manufacturing of its Covid-19 vaccine candidate.
Novavax Awarded $1.6B from Operation Warp Speed contractpharma
July 08, 2020
Supports late-stage clinical development, large-scale manufacturing of NVX-CoV2373, including production of 100 million doses starting in late 2020.
Novavax Adds Two Senior Executives to Leadership Team contractpharma
June 18, 2020
Filip Dubovsky appointed SVP, chief medical officer; Silvia Taylor appointed SVP, investor relations and corporate affairs.
Novavax Awarded DoD Contract for COVID-19 Vaccine contractpharma
June 08, 2020
Agreement includes a 2020 delivery of 10 million doses of NVX‑CoV2373 for DoD for Phase II/III trials or under an EUA if approved by the FDA.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page